198 related articles for article (PubMed ID: 25711542)
1. Dissociation of event-based prospective memory and time-based prospective memory in patients with prostate cancer receiving androgen-deprivation therapy: a neuropsychological study.
Yang J; Zhong F; Qiu J; Cheng H; Wang K
Eur J Cancer Care (Engl); 2015 Mar; 24(2):198-204. PubMed ID: 25711542
[TBL] [Abstract][Full Text] [Related]
2. Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy: A cross-sectional study.
Yang J; Zhong F; Qiu J; Wang K
Asia Pac J Clin Oncol; 2015 Dec; 11(4):277-81. PubMed ID: 25856786
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.
Wu LM; Tanenbaum ML; Dijkers MP; Amidi A; Hall SJ; Penedo FJ; Diefenbach MA
Soc Sci Med; 2016 May; 156():80-9. PubMed ID: 27019142
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced prospective memory impairment in patients with breast cancer.
Cheng H; Yang Z; Dong B; Chen C; Zhang M; Huang Z; Chen Z; Wang K
Psychooncology; 2013 Oct; 22(10):2391-5. PubMed ID: 23674402
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.
Alibhai SM; Timilshina N; Duff-Canning S; Breunis H; Tannock IF; Naglie G; Fleshner NE; Krahn MD; Warde P; Marzouk S; Tomlinson GA
Cancer; 2017 Jan; 123(2):237-244. PubMed ID: 27583806
[TBL] [Abstract][Full Text] [Related]
6. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
McGinty HL; Phillips KM; Jim HS; Cessna JM; Asvat Y; Cases MG; Small BJ; Jacobsen PB
Support Care Cancer; 2014 Aug; 22(8):2271-80. PubMed ID: 24859915
[TBL] [Abstract][Full Text] [Related]
7. Prefrontal cortex involvement in the event-based prospective memory: evidence from patients with lesions in the prefrontal cortex.
Cheng HD; Wang K; Xi CH; Niu CS; Fu XM
Brain Inj; 2008 Aug; 22(9):697-704. PubMed ID: 18608204
[TBL] [Abstract][Full Text] [Related]
8. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
9. Long-term impact of androgen-deprivation therapy on physical function and quality of life.
Alibhai SM; Breunis H; Timilshina N; Naglie G; Tannock I; Krahn M; Warde P; Fleshner NE; Canning SD; Tomlinson G
Cancer; 2015 Jul; 121(14):2350-7. PubMed ID: 25809861
[TBL] [Abstract][Full Text] [Related]
10. Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer.
Gunlusoy B; Ceylan Y; Koskderelioglu A; Gedizlioglu M; Degirmenci T; Ortan P; Kozacioglu Z
Urology; 2017 May; 103():167-172. PubMed ID: 28188757
[TBL] [Abstract][Full Text] [Related]
11. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
12. Time-based prospective memory impairment in patients with thalamic stroke.
Cheng H; Tian Y; Hu P; Wang J; Wang K
Behav Neurosci; 2010 Feb; 124(1):152-158. PubMed ID: 20141290
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in prostate cancer patients taking androgen deprivation therapy.
Dacal K; Sereika SM; Greenspan SL
J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
[TBL] [Abstract][Full Text] [Related]
14. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis.
Chao HH; Uchio E; Zhang S; Hu S; Bednarski SR; Luo X; Rose M; Concato J; Li CS
BMC Cancer; 2012 Aug; 12():371. PubMed ID: 22925152
[TBL] [Abstract][Full Text] [Related]
15. The effects of androgen deprivation on working memory and quality of life in prostate cancer patients: The roles of hypothalamic connectivity.
Chaudhary S; Zhornitsky S; Roy A; Summers C; Ahles T; Li CR; Chao HH
Cancer Med; 2022 Sep; 11(18):3425-3436. PubMed ID: 35315585
[TBL] [Abstract][Full Text] [Related]
16. Physical function in men with prostate cancer on androgen deprivation therapy.
Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
Basaria S; Muller DC; Carducci MA; Egan J; Dobs AS
Cancer; 2006 Feb; 106(3):581-8. PubMed ID: 16388523
[TBL] [Abstract][Full Text] [Related]
18. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
[TBL] [Abstract][Full Text] [Related]
20. Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer.
Alibhai SM; Breunis H; Timilshina N; Marzouk S; Stewart D; Tannock I; Naglie G; Tomlinson G; Fleshner N; Krahn M; Warde P; Canning SD
J Clin Oncol; 2010 Dec; 28(34):5030-7. PubMed ID: 21041708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
